Regulating Drug Exclusivity in the Marketplace (U.S. Pharmaceutical Regulation: Understanding the Policy, Law and Economics,)
October 21, 2021
Webinar
Harvard Kennedy School
Finnegan partner Ryan O’Quinn will join a panel discussion on how small molecule drug exclusivity is regulated in the U.S., as part of a Harvard Kennedy School webinar. For more information, please see the Harvard Kennedy School’s website.
